Tabla de Contenidos:
  • Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population
  • Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study
  • Prevalence of HCV genotypes in Poland - the EpiTer study
  • Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases
  • The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin
  • The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation.